Subscribe To Our Free Newsletter |
Zydus Life gains on USFDA nod for prostatic hyperplasia drug
Zydus Lifesciences rose 1.03% to Rs 994 after the company announced that it has received final approval from the United States Food and Drug Administration (USFDA) to market Finasteride and Tadalafil capsules USP.